Recent 8-K filings for TDAC
Highest-materiality recent filing
TDAC to merge with battery maker ProLogium at ~$3.8B enterprise value
- Deal implies ~$3.8B valuation for ProLogium on a net cash-free basis.
- Combined company to be named ProLogium Technology and list on Nasdaq as PRLG.
-
TDAC shareholders approve extension to June 2027; ~$27.8M redeemed at $10.70/share
Shareholders approved extending business combination deadline from June 24, 2026 to June 24, 2027 via up to 12 monthly extensions.
-
Translational Development converts 4.66M Class B shares to Class A; no cash proceeds
4,657,499 Class B ordinary shares converted to an equal number of Class A shares by Sponsor TDAC Partners LLC.
-
TDAC to merge with battery maker ProLogium at ~$3.8B enterprise value
Deal implies ~$3.8B valuation for ProLogium on a net cash-free basis.
-
Translational Development Acquisition Corp. obtains up to $2M working capital loan from sponsor
Sponsor TDAC Partners LLC provides up to $2,000,000 non-interest bearing loan for working capital.
-
TDAC announces separate trading of Class A shares and warrants effective Feb 14
Separate trading of Class A ordinary shares (TDAC) and warrants (TDACW) commenced Feb 14, 2025.
-
SPAC Translational Development closes $172.5M IPO; auditor flags going concern
IPO of 17,250,000 units at $10.00/unit (including over-allotment), gross proceeds $172.5M.
-
SPAC Translational Development closes $172.5M IPO with full over-allotment
IPO of 17.25M units at $10/unit raised $172.5M gross; units list on Nasdaq under TDACU.
Materiality & sentiment trend
Max materiality 0.90 · Median 0.55 · Most common event other_material